AJP - Heart AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 289: H37-H47, 2005. First published March 11, 2005; doi:10.1152/ajpheart.01057.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/1/H37    most recent
01057.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tokarska-Schlattner, M.
Right arrow Articles by Schlattner, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tokarska-Schlattner, M.
Right arrow Articles by Schlattner, U.

Acute toxicity of doxorubicin on isolated perfused heart: response of kinases regulating energy supply

Malgorzata Tokarska-Schlattner,1,* Michael Zaugg,2,3,* Rafaela da Silva,2,3 Eliana Lucchinetti,2,3 Marcus C. Schaub,2 Theo Wallimann,1 and Uwe Schlattner1

1Institute of Cell Biology, Swiss Federal Institute of Technology, 2Institute of Pharmacology and Toxicology, University of Zürich, and 3Institute of Anesthesiology, University Hospital of Zürich, Zürich, Switzerland

Submitted 14 October 2004 ; accepted in final form 5 March 2005

Doxorubicin (DXR) is a widely used and efficient anticancer drug. However, its application is limited by the risk of severe cardiotoxicity. Impairment of cardiac high-energy phosphate homeostasis is an important manifestation of both acute and chronic DXR cardiotoxic action. Using the Langendorff model of the perfused rat heart, we characterized the acute effects of 1-h perfusion with 2 or 20 µM DXR on two key kinases in cardiac energy metabolism, creatine kinase (CK) and AMP-activated protein kinase (AMPK), and related them to functional responses of the perfused heart and structural integrity of the contractile apparatus as well as drug accumulation in cardiomyocytes. DXR-induced changes in CK were dependent on the isoenzyme, with a shift in protein levels of cytosolic isoenzymes from muscle-type CK to brain-type CK, and a destabilization of octamers of the mitochondrial isoenzyme (sarcometric mitochondiral CK) accompanied by drug accumulation in mitochondria. Interestingly, DXR rapidly reduced the protein level and phosphorylation of AMPK as well as phosphorylation of its target, acetyl-CoA-carboxylase. AMPK was strongly affected already at 2 µM DXR, even before substantial cardiac dysfunction occurred. Impairment of CK isoenzymes was mostly moderate but became significant at 20 µM DXR. Only at 2 µM DXR did upregulation of brain-type CK compensate for inactivation of other isoenzymes. These results suggest that an impairment of kinase systems regulating cellular energy homeostasis is involved in the development of DXR cardiotoxicity.

creatine kinase; adenosine 5'-monophosphate-activated protein kinase; anthracyclines; cardiac energetics; cardiotoxicity



Address for reprint requests and other correspondence: U. Schlattner, Institute of Cell Biology, Swiss Federal Institute of Technology, Hönggerberg HPM F23, CH-8093 Zürich, Switzerland (E-mail: schlattn{at}cell.biol.ethz.ch)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. M. Hadzimichalis, S. S. Baliga, R. Golfetti, K. M. Jaques, B. L. Firestein, and G. F. Merrill
Acetaminophen-mediated cardioprotection via inhibition of the mitochondrial permeability transition pore-induced apoptotic pathway
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3348 - H3355.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.